NOTCH1 and neoplasm: In addition, co-loaded nanoparticles containing doxorubicin and the Notch1-inhibitor miR-34a affected TNBC cell migration more effectively and allowed enhanced tumor growth suppression compared with the drug alone in vitro and in vivo [509].